ORIGINAL RESEARCH article
Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1660984
Global trajectory and spatiotemporal epidemiological landscape of multidrug-resistant tuberculosis of spanning 46 years (1990-2035): Implications for achieving global End TB goals
Provisionally accepted
- 1Yunnan Center for Disease Control and Prevention, Kunming, China
- 2Chongqing Three Gorges Medical College, Chongqing, China
- 3Chinese Center for Disease Control and Prevention, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Although MDR-TB is recognized as a significant threat, systematic descriptions of its long-term (>30 years) global spatiotemporal evolution patterns are still limited. Objectives: This study conducted a 46-year spatiotemporal analysis of global MDR-TB (1990–2035) to provide key evidence for evaluating and refining the WHO End TB Strategy. Methods: We used Global Burden of Disease data to identify identified temporal inflection points in ASIR, ASDR, and DALYs using Joinpoint regression. Spatial clustering was quantified using Moran’s I and Getis-Ord hotspot analysis. A Bayesian age-period-cohort model projected MDR-TB incidence from 2022 to 2035. Results: The male-to-female ratio was approximately 1.5:1. Incidence was highest at 30–60 years, deaths at 60+, DALYs peak at 45–60; children under 14 years of age significantly affected. ASIR rose from 0.97/100k (1990) to 6.39/100k (2000), then declined (APC: -3.15%) post-2005 to 5.62/100k (2021); males exhibited a sharper increase (+2.39%) and slower decline (-0.71%). ASDR peaked at 2.12/100k (2002; males 27% higher). DALYs peaked at 89.05/100k (2003). Sub-Saharan Africa is hyperendemic (Moran’s I=12.38, P<0.001; Somalia:57.25/100k), with high-high clusters in Africa/Kyrgyzstan. Projections: Global ASIR declines modestly (-1.62% by 2035), but 480,000 cases expected due to population growth; female incidence drops 7.27% (2025+), male trends stable. Conclusions: MDR-TB has proven more challenging than anticipated, with persistent hotspots in sub-Saharan Africa and a disproportionate impact on males, the elderly, and children. Despite a marginal decline in ASIR to 5.46 per 100,000, the absolute number of cases is projected to rise to 480,000 by 2035 due to sustained population growth and aging. This will seriously hinder the WHO End TB Strategy. Addressing MDR-TB should prioritize key populations and regions, targeted resources, tailored interventions, sustained investment in diagnostics and treatment, and stronger government support for patient care.
Keywords: Multidrug-resistant tuberculosis, global, Incidence, death, Disability-adjusted life years
Received: 07 Jul 2025; Accepted: 18 Sep 2025.
Copyright: © 2025 Yang, Yang, Li, Su, Jiang, Liu, Ruan and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yunzhou Ruan, ruanyz@chinacdc.cn
Lin Xu, 123316859@qq.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.